GovChime
Notice ID: 3bc2558f811bec0b30491cda95fe42ffPresolicitation

synthesis, analysis and delivery of cyPNA monomers

Archived on August 21, 2018. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−05:00
Posted
July 24, 2018
Notice type
Presolicitation
NAICS
541380: Testing Laboratories and Services

Notice details

Place of performance
Bethesda, MD, 20892
PSC
B: SPECIAL STUDIES/ANALYSIS, NOT R&D
Last updated
Dec 6, 2025

Identifiers

Solicitation number
NICHD201800071
Notice ID
3bc2558f811bec0b30491cda95fe42ff

Description

INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND- NAME). The National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Acquisitions (OA) on behalf of the National Institute of Digestive, Diabetes & Kidney Diseases intends to award a purchase order without providing for full and open competition (Including brand-name) to CHEMISTRY RESEARCH SOLUTION LLC for the synthesis, analysis and delivery of 4 g of each Fmoc-Cyclopentane PNA (cyPNA) monomers. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $15,000,000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-98 This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($250,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of 41 U.S.C. 253(c) under provisions of the statutory authority of FAR Subpart 6.302- FAR 6.302-1-Only one responsible source and no other supplies or services will satisfy agency requirements 41 U.S.C. 253(c)(1). PERIOD OF PERFORMANCE 90 days from award of Contract ? Place of Performance National Institutes of Health National Institute of Digestive, Diabetes & Kidney Diseases 8 Center Drive Bethesda MD 20892 DESCRIPTION OF REQUIREMENT Chemists in the NIDDK Synthetic Bioactive Molecules Section (HNK6MA) have designed and synthesized a series of new molecules called cyclopentane peptide nucleic acids (cyPNAs). Some of these molecules are potential components for diagnostic kits to be used for the rapid detection of nucleic acids associated with diseases. The development of new diagnostic kits to signal the early stages of infections or cancers could be of great benefit to human health and thus to NIDDK's mission. In order to make cyPNAs and study their binding to nucleic acid sequences, it is essential to have the correct starting materials. The Appella lab has shown that the incorporation of trans-cyclopentanediamine into PNA backbones improves binding to target nucleic acid sequences. Our research on cyPNA development for the detection of nucleic acids associated with diseases therefore depends on the purchase of the chemicals to be custom synthesized in this order. Substantial in vitro work has been done to select cyPNAs to move forward as probes for diseases, which has incurred substantial investment. The company, Abzena, is a full-service contract research organization (CRO) fully familiar with the technical documentation required by the Food and Drug Administration (FDA). Abzena was originally recommended by the chemists at NCATS who work on the drug development program for orphan diseases. This is a highly specific research-based contract to make materials that are not commonly produced. These are synthetic materials that do not occur naturally and must be made using custom protocols developed by the NIDDK chemists. We have tried other sources and encountered technical difficulties, therefore a highly recommend and experienced contractor is essential. The objective of the research is to advance the testing of cyPNA as probes to signal the presence of infection or disease. To properly make cyPNA oligomers, the lab must have the correct building blocks that will be made in the proposed contract. Using the procedures provided by the NIDDK chemists, the company must scale up the production of the cyPNA monomer building blocks and deliver 4 g of each monomer to the NIDDK lab. Monomers received will be used to make cyPNA probes to target specific nucleic acids sequences associated with infection or disease. Results from each set of tests done are added to the file that will eventually be submitted for FDA approval as a new diagnostic test. The continuity of the project is enhanced by the use of as few CRO's as possible and only ones technically qualified to meet the specific needs of the research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: descriptive literature, delivery timeframe, warranties and/or other information that demonstrates that the offer meets all the foregoing requirements, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses to this notice shall be submitted electronically by 9:00 am Eastern Standard Time, on Monday, August 6, 2018 to the Contract Specialist, Amber Harris, at amber.harris@nih.gov . Assessment of Capability Lowest Price Technically Acceptable

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:NICHD201800071
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentJul 24, 2018

    synthesis, analysis and delivery of cyPNA monomers

    Notice 3bc2558f811bec0b30491cda95fe42ff on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Laboratory Analysis of Water Samples (i) This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued. (ii) Solicitation number 140RR027Q0021 is issued as a Request for Quote (RFQ). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, as of March 1, 2026. (iv) This acquisition is open market, with no small business set aside. The NAICS code is 541380 ¿ Testing Laboratories and Services and the size standard is $19 million. (v) The contract line items are listed in the price schedule of the solicitation package. Please provide your rate for each test. (vi) This requirement is to acquire contractor services to provide laboratory analysis of water samples for the Central California Area Office - New Melones, as identified in this PWS. (vii) The period of performance is expected to be 5 years, a base year and 4 option years, from Jan 2027 ¿ Jan 2032. (viii) Provision 52.212-1, Instructions to Offerors - Commercial Products and Commercial Services, applies to this acquisition. The quote package will consist of the vendor¿s pricing information, capability statement, ELAP Certification, and past performance references. (ix) Provision 52.212-2, Evaluation - Commercial Products and Commercial Services, applies to this acquisition. Refer to this provision for information. (x) Clause 52.212-4, Contract Terms and Conditions - Commercial Products and Commercial Services, applies to this acquisition. There are not any addenda to this clause. (xi) All additional contract clauses and provisions are included in the attached solicitation package. (xii) The Defense Priorities and Allocations System (DPAS) do not apply to this acquisition. (xii) Quotes are due December 2, 2026 by 3:00 PM (Pacific Standard Time) and should be emailed to sherry_heibeck@ios.doi.gov.
69%
Combined Synopsis12/02/2026
The U.S. Geological Survey Louisiana Water Science Center, Baton Rouge, LA requires analysis of SPATT samples for microcystin, anatoxin, cylindrospermopsin and saxitoxin congeners. The period of performance is one year ARO. There are four option years Competitive Request for Quotations (RFQ) 140GG027Q0022 is a small business set aside under NAICS code 541380 Testing Laboratories The size standard is $19 million. Question cutoff: 2 days prior to the closing of the solicitation The anticipated award date of the contract is 7 days after the solicitation closes. SAM REQUIREMENT- Offeror must be registered in the SAM - SYSTEM FOR AWARD MANAGEMENT database before an award can be made to them. All responsible sources may submit a quotation which shall be considered by the agency. All questions shall be emailed to mindie_dixon@ios.doi.gov Quotations shall be submitted to Mindie Dixon at mindie_dixon@ios.doi.gov
67%
Solicitation11/16/2026
STABLE ISOTOPE SAMPLE ANALYSIS
67%
AwardedOpen
***** This Amendment is to Extend the Due Time to 3:00 PM EST 17 April 2026 *****The work required under this agreement will primarily involve analysis of water, chlorophyll, phytoplankton, and benthic macroinvertebrates samples. All work shall be performed in strict compliance with the attached specifications and all other terms, clauses, and conditions incorporated herein. Quotes are due on 17 April 2026 at 11:00 AM Eastern Time.
66%
Solicitation04/17/2026
Please see Attached Solicitation for Performance Work Statement.
66%
AwardedOpen

Additional Details

Solicitation Number

NICHD201800071

Archive Date

Aug 21, 2018